Rheumatology and psychiatry: allies in times of COVID-19

Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel Francisco Ugarte Gil

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

Resumen

The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

Idioma originalInglés
PublicaciónClinical Rheumatology
DOI
EstadoAceptada/en prensa - 2021
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2021, International League of Associations for Rheumatology (ILAR).

Huella

Profundice en los temas de investigación de 'Rheumatology and psychiatry: allies in times of COVID-19'. En conjunto forman una huella única.

Citar esto